JMDC Inc.

4483.T
Health Information Services
2026/08/24 Updated
Market Cap: $1.4B (¥221.9B)
Stock Price: $21.29 (¥3,390)
Exchange Rate: 1 USD = ¥159.24

FY2026 March Full-Year Financial Results Briefing Materials

For the fiscal year ending March 2026, consolidated revenue was ¥50,462 million (up 21% YoY), and consolidated EBITDA was ¥13,178 million (up 21% YoY), demonstrating steady growth.

Importance:
Page Updated: May 8, 2026
IR Disclosure Date: May 8, 2026

Key Figures

  • Consolidated Revenue: ¥50,462 million (up 21% YoY)
  • Consolidated EBITDA: ¥13,178 million (up 21% YoY)
  • Net Income Attributable to Owners of Parent (Continuing Operations): ¥7.1 billion (up 5% YoY)

AI要約

Performance Overview

For the fiscal year ending March 2026, consolidated revenue was ¥50,462 million (up 21% YoY), and EBITDA was ¥13,178 million (up 21% YoY), reflecting steady growth. The core segment, the Healthcare Big Data Business, led the growth, expanding in industry-specific, insurer and consumer, and healthcare provider sectors. The telemedicine business also maintained high profitability supported by solid demand.

Shareholder Return and Future Outlook

For FY2026, a dividend of ¥18 per share is planned, while the dividend forecast for FY2027 is undecided. The FY2027 forecast includes revenue of ¥60.5 billion (up 20% YoY), operating profit of ¥11.5 billion (up 9%), and EBITDA of ¥15.0 billion (up 14%). The company aims to accelerate strategic investments in AI and data infrastructure to sustain ongoing business expansion.

Quarterly Trends in Consolidated Revenue

Quarterly Trends in Consolidated EBITDA

Segment Revenue Share for FY2026

Segment EBITDA Share for FY2026

FY2027 Earnings Forecast vs. YoY Comparison

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

JMDC Inc.

Company overview · Stock price · Financial data · All IR

View company page →